Influenza vaccine, surface antigen, inactivated (Abbott Biologicals)

流感病毒裂解疫苗(Abbott Biologicals)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInfluenza vaccine, surface antigen, inactivated (Abbott Biologicals)
Drug Alias NameN/A
ClassificationVaccines > Development/production technology > Inactivated vaccine > Split vaccineVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine +[4
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsInfluenza, Human
Approved Indications in ChinaInfluenza, Human
Original Approved Country/TerritoryEU
Original Approved Date1998/02/16
Country/TerritoryEUMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaWithdrawn
Originator CompaniesAbbott Biologicals Llc
China Registration ClassN/A

Develop Information

Active CompaniesAbbott Biologicals Llc
Inactive CompaniesN/A
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A